For the Quarter Ending March 2026
Progesterone Prices in APAC
- In China, the Progesterone Price Index rose by 3.55% quarter-over-quarter, reflecting tightening supply and stronger export inquiries.
- The average Progesterone price for the quarter was approximately USD 179313.33/MT, measured on FOB Shanghai terms.
- Progesterone Spot Price liquidity tightened in March as smaller solvent-intensive workshops idled, reducing available spot volumes.
- Progesterone Price Forecast shows near-term firmness driven by constrained diosgenin supplies and regulatory-driven batching delays.
- Progesterone Production Cost Trend rose modestly owing to tighter diosgenin availability and solvent cost pressures during winter inspections.
- Progesterone Demand Outlook remains supportive as public-hospital tenders and fertility clinic procurement accelerated in March.
- Progesterone Price Index volatility increased mid-quarter driven by inventory drawdowns and competitive export redirecting to Asia and Europe.
- Inventory cover decreased in Shanghai as coastal producers fulfilled export contracts while smaller inland plants paused for environmental inspections.
Why did the price of Progesterone change in March 2026 in APAC?
- Domestic production constraints from environmental inspections and diosgenin harvest timing tightened supply during March, lifting price pressure.
- Stronger export enquiries from India and Brazil increased urgent shipments, drawing down local inventories and supporting FOB offers.
- Elevated feedstock costs, especially diosgenin scarcity and solvent pressures, raised production costs, narrowing margins and justifying price increases.
Progesterone Prices in Europe
- In Germany, the Progesterone Price Index rose by 3.55% quarter-over-quarter, reflecting tighter imports and procurement.
- The average Progesterone price for the quarter was approximately USD 179400.00/MT with subdued spot buying.
- Progesterone Spot Price firmed in March as diosgenin tightness reduced export volumes and tightened inventories.
- Progesterone Price Forecast shows short-term upside as European buyers restock amid freight uncertainties and premia.
- Progesterone Production Cost Trend stayed steady, though higher diosgenin and compliance costs pressured exporter margins.
- Progesterone Demand Outlook remains positive driven by womens-health and fertility therapy growth supporting steady procurement.
- Progesterone Price Index gains amplified by low Hamburg free-zone stocks and limited secondary origin shipments.
- Exporters' disciplined output and unchanged freight levels sustained upward pressure on the Progesterone Price Index.
Why did the price of Progesterone change in March 2026 in Europe?
- Tighter diosgenin feedstock and disciplined Asian operating rates reduced shipments, tightening German import availability materially.
- Higher Asian conversion margins, elevated European gas tariffs and freight raised landed costs CFR Hamburg.
- German formulators accelerated bookings to secure near-term coverage, lifting spot demand and intensifying buyer urgency.
Progesterone Prices in North America
- In USA, the Progesterone Price Index rose by 3.55% quarter-over-quarter, reflecting replacement costs and demand.
- The average Progesterone price for the quarter was approximately USD 179406.67/MT, reflecting subdued procurement routines.
- Progesterone Spot Price tightened as container freight increases and Chinese emission audits reduced export volumes.
- Progesterone Price Forecast signals gains as spring procurement and higher landed costs sustain upward pressure.
- Progesterone Production Cost Trend rose with solvent and compliance expenses increasing exporter offer levels worldwide.
- Progesterone Demand Outlook remains supportive as IVF scheduling and hormone-replacement prescriptions maintain procurement through spring.
- Progesterone Price Index recorded a March uptick driven by freight increases and tighter exportable supply.
- Inventory levels remained comfortable earlier, but March replenishment buying and freight hikes tightened spot availability.
Why did the price of Progesterone change in March 2026 in North America?
- Freight increases and Chinese emission audits constrained export headroom, elevating landed costs and supplier offers.
- Stronger seasonal IVF scheduling and steady hormone-replacement prescriptions increased procurement urgency, supporting higher import bids.
- Container freight rises, solvent expense inflation in India increased production cost pressures, narrowing arbitrage margins.
For the Quarter Ending December 2025
North America
- In the USA, the Progesterone Price Index rose by 0.1% quarter-over-quarter, driven by tighter supply chains.
- The average Progesterone price for the quarter was approximately USD 173253.33/MT on a CFR Los Angeles basis.
- Progesterone Spot Price offers softened in December as falling China-US freight lowered landed costs and supplier competition increased.
- Progesterone Price Forecast indicates mild declines into early 2026 before modest recovery driven by seasonal restocking and steady demand.
- Progesterone Production Cost Trend showed elevated feedstock and conversion costs squeezing margins despite lower freight and stable diosgenin.
- Progesterone Demand Outlook remains constructive for HRT and fertility segments, supporting baseline offtake despite seasonal pauses.
- Progesterone Price Index volatility moderated as inventories remained adequate and import arrivals outpaced end-of-quarter offtake.
- Competitive Asian offers and uninterrupted producer operations pressured spot offers while buyers delayed aggressive replenishment.
Why did the price of Progesterone change in December 2025 in North America?
- Reduced China-US container rates significantly lowered landed import costs, directly easing December CFR Los Angeles prices.
- Year-end destocking by pharmaceutical and veterinary buyers trimmed spot demand, pressuring near-term quotes downward modestly.
- Stable diosgenin and routine Asian production kept supply available, limiting upward pressure despite firm downstream offtake.
APAC
- In China, the Progesterone Price Index rose by 0.1% quarter-over-quarter, driven by upstream supply tightness and freight inflation.
- The average Progesterone price for the quarter was approximately USD 173166.67/MT on an FOB Shanghai basis.
- Progesterone Spot Price remained firm amid inventory drawdowns and freight cost increases impacting export competitiveness.
- Progesterone Price Index displayed narrow range movement, reflecting balanced supply and subdued downstream procurement sentiment.
- Progesterone Production Cost Trend was upward due to higher freight, feedstock tightness and winter environmental compliance costs.
- Progesterone Demand Outlook remains moderate with seasonal veterinary and IVF requirements offsetting weakness in hospital tendering.
- Inventory drawdowns in Shanghai warehouses supported export coverage while traders withheld lots, affecting short-term Price Index readings.
- Progesterone Price Forecast anticipates slight fluctuations given logistic variability, regulatory controls and stable diosgenin harvests.
Why did the price of Progesterone change in December 2025 in APAC?
- Port congestion eased but freight remained elevated, increasing landed costs and supporting marginal upward pressure.
- Winter environmental shutdowns trimmed secondary workshop output, tightening intermediate availability and pressuring spot shipment volumes.
- Seasonal softening of export enquiries and domestic hospital tender pauses reduced immediate demand, causing modest downward influence.
Europe
- In Germany, the Progesterone Price Index rose by 0.1% quarter-over-quarter, supported by tight global API supply.
- The average Progesterone price for the quarter was approximately USD 173248.33/MT, based on landed Hamburg import totals.
- Progesterone Spot Price remained pressured by competitive Asian offers and timely arrivals, keeping short-term landed levels subdued.
- Progesterone Production Cost Trend showed limited upside as energy input costs stayed flat, constraining producer margin-driven price hikes.
- Progesterone Demand Outlook remained firm for HRT and fertility therapies, supporting steady procurement but limiting aggressive spot buying.
- Progesterone Price Forecast indicates modest fluctuations, with seasonal restocking and supply normalization driving minor monthly percentage adjustments.
- Inventory buffers in European warehouses were modest, and Progesterone Price Index sensitivity increased due to constrained import volumes.
- Port and freight stability limited additional landed-cost pressure, while buyers applied year-end discipline affecting near-term procurement intensity.
Why did the price of Progesterone change in December 2025 in Europe?
- Timely Asian arrivals eased supply tightness, reducing urgency and exerting downward influence on landed prices.
- Stable energy and freight costs removed input-driven upward pressure despite firm pharmaceutical demand and restocking.
- Euro strengthening trimmed dollar-denominated landed costs, nudging CFR Hamburg quotes slightly lower in December period.
For the Quarter Ending September 2025
North America
- In USA, the Progesterone Price Index rose by 0.87% quarter-over-quarter, reflecting supply constraints and elevated logistics.
- The average Progesterone price for the quarter was approximately USD 173132.00/MT, reflecting CFR Los Angeles basis.
- Tight inventories kept the Progesterone Spot Price elevated, while the Progesterone Price Index signaled momentum.
- Rising feedstock and compliance expenses supported an upward Progesterone Production Cost Trend, pressuring supplier margins.
- The Progesterone Demand Outlook remained firm due to HRT formulation cycles and procurement by CDMOs.
- Short-term Progesterone Price Forecast projects slight gains driven by logistics pressures and precautionary buying patterns.
- Port congestion and front-loading elevated landed costs, constraining flows and amplifying Progesterone Price Index volatility.
- Distributors prioritized secure supply over price, building inventories and sustaining elevated Progesterone Price Index readings.
Why did the price of Progesterone change in September 2025 in North America?
- Supply constraints from Chinese curtailments and elevated freight raised landed costs, tightening spot availability September.
- Front-loaded procurement ahead of tariff changes compressed near-term volumes, sustaining upward pricing pressure on imports.
- Currency weakness and higher inputs increased importers' landed costs, while port congestion extended lead times.
APAC
- In China, the Progesterone Price Index rose by 0.894% quarter-over-quarter, reflecting production costs, supply constraints.
- The average Progesterone price for the quarter was approximately USD 173033/MT, citing input cost pressures.
- Progesterone Spot Price firmed as immediate shipment availability tightened due to port congestion and typhoon-related logistics disruption.
- Progesterone Production Cost Trend pointed upward with higher fermenter input prices and increased energy and solvent expenditures.
- Progesterone Demand Outlook remained robust across pharmaceutical and veterinary sectors, driven by HRT, fertility programs.
- Progesterone Price Forecast suggests sequential small uplifts, reflecting persistent cost pressures and constrained export availability.
- Progesterone Price Index supported by buying and low inventories, sustaining export quotations in overseas markets.
- Operational downtimes from environmental inspections and upgrades curtailed output at Chinese API plants, tightening supply.
Why did the price of Progesterone change in September 2025 in APAC?
- Reduced domestic output from environmental inspections and facility upgrades constrained volumes available for export and shipment.
- Higher feedstock, energy, and solvent costs increased production expenses, prompting suppliers to raise export quotations.
- Port congestion and typhoon disruptions lengthened lead times while buyers accelerated restocking, tightening immediate availability.
Europe
- In Germany, the Progesterone Price Index rose by 0.90% quarter-over-quarter, driven by supply chain pressures.
- The average Progesterone price for the quarter was approximately USD 173137.33/MT, reflecting higher freight costs.
- Progesterone Spot Price firmed as port congestion elevated landed costs and elongated delivery lead times.
- Progesterone Price Forecast indicates upward bias driven by persistent logistical constraints and steady pharmaceutical demand.
- Progesterone Production Cost Trend shows pressure from higher freight, energy and raw material input costs.
- Progesterone Demand Outlook remains firm as pharmaceuticals and veterinary sectors replenish inventories amid supply uncertainties.
- Progesterone Price Index gains were supported by export deals and cautious restocking amid easing freight.
- Major producers maintained operations with downtime, reinforcing supply tightness and supporting higher Price Index levels.
Why did the price of Progesterone change in September 2025 in Europe?
- Persistent import delays and constrained shipments reduced volumes, intensifying landed cost pressures across European markets.
- Higher freight, demurrage and energy costs elevated production and landed costs, pressuring domestic procurement prices.
- Strong pharmaceutical procurement and export deals prompted restocking, sustaining upward price momentum despite logistical easing.
For the Quarter Ending June 2025
North America
- In Q2 2025, Progesterone spot price index in North America experienced a mildly upward trend, averaging a modest quarter-over-quarter increase of approximately 0.12%, with spot prices ending June at aroundUSD172,688/mt, reflecting firming market conditions after a soft start.
- June’s Progesterone pricing momentum was reinforced by ongoing elevated freight rates and constrained inventories, which coupled with higher input costs at Chinese manufacturing hubs, sustained an upward pricing trajectory.
- Progesterone Production cost trends during the quarter leaned higher, primarily driven by surging global energy prices and tighter regulatory compliance costs in key exporting countries, impacting landed costs and pressuring suppliers to raise export offers.
- Progesterone Demand outlook within Q2 showed a recovery, particularly in May and June, as pharmaceutical and veterinary sectors increased procurement activity to hedge against anticipated supply disruptions and rising future costs.
- April witnessed a downward pressure on Progesterone prices due to tariff-driven market uncertainty, frontloading by importers, and ample domestic inventory, which suppressed immediate demand.
- Exporters from China and India faced cost-push inflation, notably in energy and upstream raw materials, which nudged production costs up and led to moderated price adjustments in May and June.
- Buyer behavior shifted from cautious inventory management in April towards proactive restocking by mid-Q2, motivated by tighter global supplies and anticipated price escalation in Q3.
- Pharmaceutical formulations related to women’s health drove the majority of demand gains, with hormone replacement therapy and fertility treatment segments particularly active.
- Persistent logistical challenges, including port congestion and container shortages, continued to inflate landed costs and contributed to price firmness in the latter half of Q2.
APAC
- Progesterone spot price index across APAC in Q2 2025 showed a general upward trajectory with an average quarter-over-quarter increase close to 0.1%, closing June nearUSD172,500/mt, reflecting a recovery from export price declines experienced earlier in the quarter.
- June’s Progesterone price behavior in APAC was notably bullish due to rising production costs from stringent environmental compliance and input price inflation coupled with robust global demand.
- Progesterone Production cost trends were largely impacted by stricter environmental audits in China and incremental raw material scarcity, pushing manufacturing expenses higher throughout Q2.
- The Progesterone demand outlook during the quarter improved substantially, especially from Southeast Asian, Latin American, and Indian pharmaceutical formulators replenishing inventories ahead of Q3 and anticipating regulatory shifts.
- Early Q2 was marked by oversupply and price softness driven by U.S. tariffs on Chinese imports and subdued international orders, creating inventory overhang issues.
- Mid-Q2 saw supply disruptions from temporary shutdowns in key provinces like Zhejiang and Jiangsu, leading to constrained availability and higher export prices.
- Logistics bottlenecks, including port congestion and delayed shipments from major ports like Ningbo and Shanghai, further exacerbated supply tightness and contributed to spot price increases in June.
- International buyers showed strong interest, particularly in hormone replacement therapies and reproductive health formulations, supporting firming price trends.
- Exporters adopted cautious inventory strategies, limiting aggressive discounting due to increased cost pressures and global market uncertainties, thereby reinforcing the bullish market tone.
Europe
- The European Progesterone spot price index in Q2 2025 was upward, with an average quarter-over-quarter price growth around 0.14%, and closing prices near €172,610/mt in June, underpinned by tight supply and firming downstream demand.
- June’s Progesterone pricing strength was sustained amid rising input costs, notably the spike in diosgenin feedstock prices, coupled with ongoing logistic disruptions impacting inbound shipments.
- Progesterone Production cost trends were characterized by challenges including unplanned shutdowns in India, stricter environmental audits, and rising freight rates from Asia to Europe, cumulatively increasing manufacturing and landed costs.
- Progesterone Demand outlook in Europe improved steadily through Q2, supported by pharmaceutical buyers replenishing depleted inventories and accelerating procurement to mitigate supply chain uncertainties.
- April saw price softening due to oversupply from Asian manufacturers ramping up output and strategic stockpiling by cautious buyers awaiting further price developments.
- May marked a reversal with supply tightening from key exporters and increased upstream costs, prompting a rebound in prices supported by improved procurement activity.
- Logistical complications, including congestion in major ports like Hamburg, Rotterdam, and Antwerp, labor shortages, and low Rhine water levels, contributed to extended lead times and higher freight costs in June.
- Currency fluctuations, with a moderately stronger euro versus the U.S. dollar, slightly mitigated import cost pressures and supported buyer confidence in procuring supplies.
- Downstream sectors such as pharmaceuticals and healthcare showed resilience and actively adapted procurement strategies, maintaining sustained purchasing momentum that underpinned the progressively bullish market environment for Progesterone in Europe.
